“We are vehement to be operative with Tom Strauss, who has a prolonged and determined lane record of forward-looking, innovative care in a sanatorium industry.”
Washington, DC (PRWEB)
January 07, 2016
NaviMed Capital, a heading medical focused private equity organisation formed in Washington, DC, currently announced a enlargement of a group with a further of an gifted sanatorium executive as a Senior Advisor to a organisation and a new employing of dual investment Associates.
- Thomas Strauss – Senior Advisor
Mr. Strauss is a former President CEO, of Summa Health System, a vital Ohio-based medical complement with $1.6 billion of revenue. During his 15-year reign and underneath his leadership, Summa Health System generated a $2.9 billion mercantile impact. With approximately 10,000 employees, it is a largest employer in all 5 counties that it serves. In before years, Mr. Strauss spent 10 years during Meridia Cleveland Clinic in care roles where he determined new ventures, incited around programs and services, and increasing marketplace share. In addition, he worked during Baxter Healthcare.
Mr. Strauss perceived his Doctor of Pharmacy and his Bachelor of Science both from Duquesne University in Pittsburgh. He was Board Chair during Greater Akron Chamber of Commerce, Board Member during Premier, Austen BioInnovation Institute, United Way of Summit County, Team.NEO, BioEnterprise, and Akron Tomorrow. He is a target of a Outstanding Fundraiser Award, Community Service Award, Northeast Ohio Business Hall of Fame and was named Non-Profit Executive of a Year, Pillar Award for Community Service.
- Cyrus Peyrovian – Associate
Prior to fasten NaviMed Capital, Mr. Peyrovian was partial of a Business Development group during Healthagen, a multiplication of Aetna focused on providing a apartment of payer-neutral race health government services and HIT solutions. Based out of New York, he upheld Healthagen’s portfolio of businesses, including Accountable Care Solutions, Medicity, and Active Health, by partnership, investment, and merger activities.
Mr. Peyrovian started his career as an investment banking researcher during SunTrust Robinson Humphrey, focused on MA advisory and collateral lifting exchange opposite a series of medical sectors.
Mr. Peyrovian binds a BS in Finance and Operations Management from a University of Maryland.
- Ryan Ross – Associate
Prior to fasten NaviMed Capital, Mr. Ross was an Associate during Capitala Group, a provider of collateral to reduce and normal middle-market companies by a family of funds. Based out of Charlotte, NC, he upheld a fad and execution of over 15 investments, including control equity, minority equity, and subordinated in exchange such as leveraged buyouts, government buyouts, appendage acquisitions, and expansion financings. Notable exchange embody a merger of a hospice provider, a merger of medical device manufacturer, and a expansion financing of bioscience company, along with mixed add-ons acquisitions.
Mr. Ross binds a BS in Finance from East Carolina University.
These 3 additions join a NaviMed comparison investment group that has a lane record of value origination travelling dozens of investments and some-more than $6.5 billion of craving value total with some-more than 50 years of total medical investing and handling experience.
“As we pursue new expansion investment opportunities, all of us during NaviMed are really vehement to be expanding a group with such high peculiarity and gifted individuals,” pronounced Brian Canann, Managing Director of NaviMed Capital. “We are quite vehement to be operative with Tom Strauss, who has a prolonged and determined lane record of forward-looking, innovative care in a sanatorium industry.”
About NaviMed Capital
NaviMed Capital is a Washington, DC-based private collateral organisation focused exclusively on a medical industry. NaviMed creates estimable investments in quick flourishing reduce middle-market medical businesses. The organisation concentration on medical services, medical IT, sanatorium products, and placement businesses that are staid to advantage from a remodel and record origination army reshaping a medical industry. NaviMed targets essential private companies with adult to $10 million of EBITDA and double number income growth. NaviMed seeks investments that can advantage from a low attention expertise, extended attribute network and total 50+ year lane record of success as medical investors and operators. NaviMed’s comparison investment group has a lane record of value origination travelling dozens of investments and some-more than $6.5 billion of craving value created.
For some-more information, greatfully revisit http://www.navimed.com
Article Original Source: Click here for details